Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
21 May 2019 Rendering the Tumour Microenvironment More Sensitive to PD-1 Blockade Breast cancer - Cancer Immunology and Immunotherapy
20 May 2019 FDA Approves Venetoclax for CLL and SLL Haematologic malignancies - Anticancer agents & Biologic therapy
17 May 2019 FDA Approves Avelumab Plus Axitinib for Renal Cell Carcinoma Genitourinary cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
16 May 2019 Next Generation Profiling of the Cancer Cell Line Encyclopedia Basic science - Translational research
15 May 2019 How to Improve Access to Expertise in Cancer Imaging Diagnosis, Imaging and Staging
13 May 2019 FDA Approves Ramucirumab for Hepatocellular Carcinoma Gastrointestinal cancers - Anticancer agents & Biologic therapy
10 May 2019 EMA Recommends Granting a Marketing Authorisation for New Biosimilar Pegfilgrastim Palliative and supportive care
09 May 2019 FDA Approves Ado-trastuzumab Emtansine for Early Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
08 May 2019 EMA is Updating the Prescribing Information for Lapatinib Breast cancer - Anticancer agents & Biologic therapy
07 May 2019 EMA Recommends Refusal of a Marketing Authorisation for Cabazitaxel Teva Genitourinary cancers - Anticancer agents & Biologic therapy
06 May 2019 FDA Approves Ivosidenib as First-Line Treatment for AML with IDH1 Mutation Haematologic malignancies - Cancer in Special Situations / Population - Personalised medicine - Anticancer agents & Biologic therapy
04 May 2019 Patients aged 75-79 years at higher risk of distant recurrence than patients aged 70-74 years in the older population (>70 years) of patients with early stage breast cancer despite higher competing mortality Breast cancer - Cancer in Special Situations / Population
03 May 2019 EMA Recommends an Extension of Therapeutic Indication for Olaparib Gynaecologic malignancies - Personalised medicine - Anticancer agents & Biologic therapy
02 May 2019 De-escalation of Commonly Used Bone-Treating Agents Is A Reasonable Treatment Option for Patients with Bone Metastases from Breast Cancer Breast cancer - Palliative and supportive care
02 May 2019 Molecular Analysis of Samples from the AURORA Programme Is Underway Breast cancer - Translational research